People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Pharma, Biotechnology, Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ansun Biopharma, Inc. | — | Pharma | Series C | $195.1M | $3.5B | 2010 |
| Inspirna, Inc. | — | Biotechnology | Series C | $141.9M | $1.1B | 2015 |
| Kun Run Biotechnology, Inc. | — | Pharmaceuticals | Series A | $8.0M | $247.8M | 2009 |
| SensorRX, Inc. | — | Other Health Care | Seed | $1.5M | $38.3M | 2018 |
Nancy Chang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nancy Chang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jack Nielsen | 1 | 13 |
| MICHAEL CHANG | 1 | 13 |
| ANTOINE PAPIERNIK | 1 | 6 |
| Nilesh Kumar | 1 | 4 |
| Dieter Weinand | 1 | 4 |
| Eric Rowinsky | 1 | 4 |
| Raymond Camahort | 1 | 4 |
| KAREN LIU | 1 | 4 |
| Shahram Seyedin-Noor | 1 | 3 |
| Peter Van Vlasselaer | 1 | 2 |
| George McLendon | 1 | 2 |
| David Darst | 1 | 2 |
| Allen Chao | 1 | 2 |
| Michael Chao | 1 | 2 |
| Dave Chenn | 1 | 2 |
| Jue Pu | 1 | 1 |
| Michael Ginder | 1 | 1 |
| Saeed Tavazoie | 1 | 1 |
| Xiaoqun Ye | 1 | 1 |
| AIMIN WU | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.